In line with our current findings and previous reports on GDM, reduced H19 expression has been observed in serum samples and serum-derived exosomes of patients with T2DM, as well as in T2DM skeletal muscles and in animal models with induced insulin resistance [46,47]. This evidence concerns the gene H19 and Insulin resistance.